Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer

被引:2
|
作者
Song, Huiyeon [1 ]
Tran, Thi Xuan Mai [1 ]
Kim, Soyeoun [2 ]
Park, Boyoung [1 ,3 ]
机构
[1] Hanyang Univ, Coll Med, Dept Prevent Med, 222 Wangsimni Ro, Seoul 04763, South Korea
[2] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea
[3] Hanyang Univ, Hanyang Inst Biosci & Biotechnol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
TUMOR CHARACTERISTICS; MAMMOGRAPHIC DETECTION; PROGRAM; FILM;
D O I
10.1001/jamanetworkopen.2024.11927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The risk factors for interval breast cancer (IBC) compared with those for screen-detected breast cancer (SBC) and their association with mortality outcomes have not yet been evaluated among Korean women. OBJECTIVE To evaluate risk factors associated with IBC and survival among Korean women with IBC compared with those with SBC. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used data from the Korean National Health Insurance Service Database. Women who participated in a national mammographic breast cancer screening program between January 1, 2009, and December 31, 2012, were included. Mortality outcomes were calculated from the date of breast cancer diagnosis to the date of death or December 31, 2020. Data were analyzed from March 1 to June 30, 2023. EXPOSURE Breast cancer diagnosed within 6 to 24 months after a negative screening result (ie, IBC) or within 6 months after a positive screening result (ie, SBC). MAIN OUTCOMES AND MEASURES Risk factors and survival rates for IBC and SBC. RESULTS This study included 8702 women with IBC (mean [SD] age, 53.3 [8.6] years) and 9492 women with SBC (mean [SD] age, 54.1 [9.0] years). Compared with SBC, the probability of IBC decreased as mammographic density increased. Lower body mass index, menopausal status, hormone replacement therapy (HRT) use, and lack of family history of breast cancer were associated with a higher likelihood of IBC. When stratified by detection time, younger age at breast cancer diagnosis and family history of breast cancer were associated with an increased likelihood of IBC diagnosed at 6 to 12 months but a decreased likelihood of IBC diagnosed at 12 to 24 months. Overall mortality of IBC was comparable with SBC, but total mortality and cancer-related mortality of IBC diagnosed between 6 and 12 months was higher than that of SBC. CONCLUSIONS AND RELEVANCE The findings of this cohort study suggest that breast density, obesity, and HRT use were associated with IBC compared with SBC. These findings also suggest that higher supplemental breast ultrasound use among Korean women, especially those with dense breasts, could be attributed to a lower incidence of IBC among women with dense breasts compared with women with SBC, due to greater detection. Finally, overall mortality of IBC was comparable with that of SBC.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Incidence and Risk Factors of Interval and Screen-Detected Breast Cancer
    Zhang, Yuqi
    Rodriguez, Juan
    Mao, Xinhe
    Grassmann, Felix
    Tapia, Jose
    Eriksson, Mikael
    Hall, Per
    Czene, Kamila
    JAMA ONCOLOGY, 2025,
  • [2] A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer
    Dreher, Nickolas
    Matthys, Madeline
    Hadeler, Edward
    Shieh, Yiwey
    Acerbi, Irene
    McAuley, Fiona M.
    Melisko, Michelle
    Eklund, Martin
    Tice, Jeffrey A.
    Esserman, Laura J.
    Van't Veer, Laura J.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (03) : 623 - 629
  • [3] A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer
    Nickolas Dreher
    Madeline Matthys
    Edward Hadeler
    Yiwey Shieh
    Irene Acerbi
    Fiona M. McAuley
    Michelle Melisko
    Martin Eklund
    Jeffrey A. Tice
    Laura J. Esserman
    Laura J. van’t Veer
    Breast Cancer Research and Treatment, 2022, 191 : 623 - 629
  • [4] Risk Factors for Second Screen-Detected or Interval Breast Cancers in Women with a Personal History of Breast Cancer Participating in Mammography Screening
    Houssami, Nehmat
    Abraham, Linn A.
    Kerlikowske, Karla
    Buist, Diana S. M.
    Irwig, Les
    Lee, Janie
    Miglioretti, Diana L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (05) : 946 - 961
  • [5] Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
    Li, J.
    Holm, J.
    Bergh, J.
    Eriksson, M.
    Darabi, H.
    Lindstrom, L. S.
    Tornberg, S.
    Hall, P.
    Czene, K.
    ANNALS OF ONCOLOGY, 2015, 26 (03) : 517 - 522
  • [6] Overdiagnosis of screen-detected breast cancer
    Milch, Vivienne
    Aranda, Sanchia
    Canfell, Karen
    Varlow, Megan
    Roder, David M.
    Currow, David
    Anderiesz, Cleola
    Keefe, Dorothy
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (10) : 455 - +
  • [7] Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer
    Yen, Amy Ming-Fang
    Wu, Wendy Yi-Ying
    Tabar, Laszlo
    Duffy, Stephen W.
    Smith, Robert A.
    Chen, Hsiu-Hsi
    JOURNAL OF EPIDEMIOLOGY, 2017, 27 (03) : 98 - 106
  • [8] Stages of screen-detected breast cancer
    K Koufopoulos
    I Garas
    Ch Pateras
    E Ampatzoglou
    P Kakavoulis
    A Michas
    S Gravas
    V Sarrou
    D Tsitsimelis
    M Tsompanlioti
    N Papageorgiou
    K Kapridaki
    F De Waard
    Breast Cancer Research, 2 (Suppl 2)
  • [9] The Management of Screen-detected Breast Cancer
    Ahmed, Muneer
    Douek, Michael
    ANTICANCER RESEARCH, 2014, 34 (03) : 1141 - 1146
  • [10] Surgical management of women with screen-detected breast cancer: preoperative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer
    Currie, R. J.
    O'Flynn, E. A. M.
    Michell, M. J.
    BREAST CANCER RESEARCH, 2009, 11